최신 시험

EudraCT Number: 2004-000782-35

Sponsor Protocol Number: CERL080AIT06

Start Date: 2004-06-10

Sponsor Name: NOVARTIS FARMA

Full Title: EVALUATION OF THE QUALITY OF LIFE AND GASTROINTESTINAL SYMPTOMS AFTER CONVERSION TO MYFORTIC (ERL080) and CELLCEPT WITHDRAWAL IN MAINTENANCE RENAL TRANSPLANT RECIPIENTS TREATED WITH TACROLIMUS.

Medical condition: Prophylaxis of transplant rejection in adult patients receiving calcineurin inhibitors with / without corticosteroids after allogeneic renal transplants.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10023439		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000374-31

Sponsor Protocol Number: SB-683699/003

Start Date: 2004-06-09

Sponsor Name: GLAXO SMITHKLINE

Full Title: A Randomised, Double-blind, Placebo-controlled, Parallel Group, Dose-Ranging Study to Investigate the Efficacy and Safety of Three Months administration of SB 683699 (150 - 1200mg twice daily) in ...

Medical condition: Relapsing Multiple Sclerosis

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2009-017840-15

Sponsor Protocol Number: KS-2003-06

Start Date: 2004-05-31

Sponsor Name: DSC Services, s.r.o.

Full Title: Srovnání účinnosti kapecitabinu (Xeloda) s kontinuálním podáním 5-fluorouracilu v předoperační konkomitantní léčbě s radioterapií u karcinomu rekta

Medical condition: Rectal cancer stage II and III

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000376-14

Sponsor Protocol Number: CLAF237A2309

Start Date: 2004-05-28

Sponsor Name: NOVARTIS FARMA

Full Title: A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, ACTIVE CONTROLLED STUDY TO COMPARE THE EFFECT OF 52 WEEKS TREATMENT WITH LAF237 50 MG BID TO METFORMIN UP TO 1000 MG BID IN DRUG NAIVE PATIENTS WITH TYPE 2 ...

Medical condition: MONOTHERAPY TREATMENT OF PATIENTS WITH TYPE 2 DIABETES

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012601		PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-000349-40

Sponsor Protocol Number: H8O-MC-GWAO

Start Date: 2004-05-19

Sponsor Name: ELI LILLY

Full Title: Efficacy of Exenatide Compared with Insulin Glargine in Patients with Type 2 Diabetes Using Metformin or Sulfonylurea for Whom Insulin is the Next Appropriate Therapy

Medical condition: Type 2 Diabetes Mellitus

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10012607		5

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001321-25

Sponsor Protocol Number: 101596

Start Date: 2004-05-19

Sponsor Name: WYETH LEDERLE

Full Title: A prospective, open label, monocenter trial to evaluate the interaction between the Platelia Aspergillus ELISA test and the administration of piperacillin/tazobactam.

Medical condition: Evaluation of interference between platelia aspergillus ELISA TEST and administration of PIPERACILLIN/TAZOBACTAM.

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10004018		HLGT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001035-32

Sponsor Protocol Number: ISG-STS 04/03

Start Date: 2004-05-13

Sponsor Name: ITALIAN SARCOMA GROUP

Full Title: NON-MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FROM HLA IDENTICAL SIBLING FOR METASTATIC SOFT TISSUE SARCOMAS

Medical condition: METASTATIC SOFT TISSUE SARCOMAS

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10029104	Neoplasms benign, malignant and unspecified (incl cysts and polyps)	SOC

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-001253-29

Sponsor Protocol Number: KF-B-005-04

Start Date: 2004-05-13

Sponsor Name: PharmaMar SAU

Full Title: Clinical and pharmacokinetic phase II study of one hour infusion of kahalalide F administered every week to patients with Non Small Cell Lung Cancer Stage IIIB with pleural effusion and stage IV, a...

Medical condition: Non Small Cell Lung Cancer Stage IIIB and IV after first Line Chemotherapy

Disease:	Version	SOC Term	Classification Code	Term	Level
	5.0		10029514		LLT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: ES (Completed)

Trial results: View results

EudraCT Number: 2004-001647-30

Sponsor Protocol Number: ESPHALL

Start Date: 2004-04-28

Sponsor Name: A.I.E.O.P. - ASSOCIAZIONE ITALIANA EMATOLOGIA ONCOLOGIA PEDIATRICA

Full Title: An open-label study to evaluate the safety and efficacy of IMATINIB with chemotherapy in pediatric patients with Ph+/BCR-ABL+ acute lymphoblastic leukemia (Ph+ALL)

Medical condition: Children and adolescents aged 1-17 years at diagnosis, with Ph+ALL

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	100000004864	10000844	Acute lymphoblastic leukaemia	LLT

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

EudraCT Number: 2004-002973-22

Sponsor Protocol Number: CERL080AIT03

Start Date: 2004-04-28

Sponsor Name: AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I [...] 1. AZIENDA UNIVERSITARIA OSPEDALE POLICLINICO UMBERTO I 2. AZIENDA POLICLINICO UMBERTO I

Full Title: Epidemiological open-label study to evaluate the frequency of helicobacter Pylori infections prior to and after equimolar switch from therapy with MMF to enteric-coated Mycophenolic Acid (MYFORTIC-...

Medical condition: Profilaxis of rejection in stable renal transplant patients

Disease:	Version	SOC Term	Classification Code	Term	Level
	6.1		10046694		PT

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: IT (Ongoing)

Trial results: (No results available)

최신 시험

스폰서 및 공동 작업자

건강 상태

약물 개입